Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immunoadsorption vs. Plasmapheresis in the Escalation Therapy of Relapse in Multiple Sclerosis and Clinically Isolated Syndrome

NCT02671682 is registered in ClinicalTrials.gov with Albert Christian Ludolph, Prof. as lead sponsor.

NCT NCT02671682
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02671682 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immunoadsorption vs. Plasmapheresis in the Escalation Therapy of Relapse in Multiple Sclerosis and Clinically Isolated Syndrome
Lead sponsor
Albert Christian Ludolph, Prof.
Phase
Not applicable
Overall status
Completed
Start date
February 26, 2016
Completion date
January 25, 2019
Enrollment
61 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

clinically isolated syndrome, multiple sclerosis